Clinical Trials Browser

Phase NA × Amyloidosis × Dexamethasone × Clear all

NCT01383759 2020-04-07

Bortezomib/Dexamethasone (BD), Followed By Autologous Stem Cell Transplantation and Maintenance Bortezomib/Dexamethasone For the Initial Treatment of Monoclonal Immunoglobulin Deposition Disease (MIDD) Associated With Multiple Myeloma and AL Amyloidosis

Phase NA Completed

20 enrolled 16 charts

Noninsulin-dependent diabetes mellitus with deafness, Immunoglobulin Light-chain Amyloidosis, Amyloidosis

NCT00890552 2017-03-22

A Pilot Study of Lenalidomide, Melphalan and Dexamethasone in AL Amyloidosis

Phase NA Completed

25 enrolled 12 charts

Other hematologic neoplasmPlasma cell

Amyloidosis, Leukemia